Lisamaria Bracher Selected Research

leucylleucine (Leu-Leu)

1/2022

The human vault RNA enhances tumorigenesis and chemoresistance through the lysosome in hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lisamaria Bracher Research Topics

Disease

1	Carcinogenesis 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Neoplasms (Cancer) 01/2022
1	COVID-19 12/2021

Drug/Important Bio-Agent (IBA)

1	leucylleucine (Leu-Leu)IBA 01/2022
1	bafilomycin A1IBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	Betaine-Homocysteine S-Methyltransferase (Betaine Homocysteine Methyltransferase)IBA 01/2022
1	Lysosomal-Associated Membrane Protein 1IBA 01/2022
1	thiazolyl blueIBA 01/2022
1	Chloroquine (Aralen)FDA LinkGeneric 01/2022
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	EstersIBA 01/2022
1	Proton-Translocating ATPases (ATPase, H+)IBA 01/2022
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022
1	RibonucleoproteinsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Transfer RNA (tRNA)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	TransferasesIBA 01/2022
1	StaurosporineIBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	Untranslated RNA (Noncoding RNA)IBA 01/2022
1	Interferon LambdaIBA 12/2021
1	CytokinesIBA 12/2021